Hitoshi Yoshiji Selected Research

Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)

06/2007	Combined treatment of vitamin K2 and angiotensin-converting enzyme inhibitor ameliorates hepatic dysplastic nodule in a patient with liver cirrhosis.
02/2007	Synergistic inhibition of hepatocellular carcinoma growth and hepatocarcinogenesis by combination of 5-fluorouracil and angiotensin-converting enzyme inhibitor via anti-angiogenic activities.
11/2006	Interferon augments the anti-fibrotic activity of an angiotensin-converting enzyme inhibitor in patients with refractory chronic hepatitis C.
01/2006	Amelioration of carcinogenesis and tumor growth in the rat liver by combination of vitamin K2 and angiotensin-converting enzyme inhibitor via anti-angiogenic activities.
02/2005	Combination of interferon-beta and angiotensin-converting enzyme inhibitor, perindopril, attenuates the murine liver fibrosis development.
12/2003	Combination of interferon-beta and the angiotensin-converting enzyme inhibitor, perindopril, attenuates murine hepatocellular carcinoma development and angiogenesis.

Articles by Research Topic

Disease

12	Hepatocellular Carcinoma (Hepatoma) 01/2008 - 04/2002
8	Neoplasms (Cancer) 08/2007 - 03/2002
7	Liver Cirrhosis (Hepatic Cirrhosis) 11/2007 - 11/2002
3	Fibrosis (Cirrhosis) 02/2007 - 03/2003
3	Chronic Hepatitis C 11/2006 - 02/2005
2	Colorectal Neoplasms (Colorectal Cancer) 08/2007 - 07/2005
2	Carcinoma (Carcinomatosis) 09/2004 - 05/2002
1	Alcoholic Hepatitis 01/2007
1	Neoplasm Metastasis (Metastasis) 11/2006
1	Melanoma (Melanoma, Malignant) 11/2006
1	Acute Liver Failure (Fulminant Hepatic Failure) 07/2006
1	Solitary Fibrous Tumors 01/2006
1	Hypoglycemia (Reactive Hypoglycemia) 01/2006
1	Hepatomegaly 01/2006
1	Cerebral Hemorrhage 01/2006
1	Hemorrhage 11/2005

Drug/Important Bio-Agent (IBA)

6	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 06/2007 - 12/2003
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2006 - 04/2002
4	InterferonsIBA 01/2008 - 02/2005
4	Perindopril FDA Link 02/2005 - 03/2002
3	VitaminsIBA 08/2007 - 03/2005
2	Vitamin K 2 (Vitamin K2)IBA 06/2007 - 01/2006
2	Interferon-betaIBA 02/2005 - 12/2003
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 11/2004 - 11/2002
2	Tissue Inhibitor of Metalloproteinase-1IBA 09/2004 - 06/2003
1	H-cadherin (T-cadherin)IBA 11/2007
1	AdiponectinIBA 11/2007
1	Epidermal Growth Factor (EGF)IBA 02/2007
1	Fluorouracil (Carac)FDA LinkGeneric 02/2007
1	von Willebrand FactorIBA 01/2007
1	Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric 11/2006
1	Angiotensin IIIBA 10/2006
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 07/2006
1	DNA (Deoxyribonucleic Acid)IBA 05/2006
1	CytosineIBA 05/2006
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 05/2006
1	Glucose (Dextrose)FDA LinkGeneric 01/2006
1	Insulin-Like Growth Factor II (Somatomedin A)IBA 01/2006
1	GlycogenIBA 01/2006
1	Long-Acting Insulin (Insulin, Long Acting)FDA Link 01/2006
1	Ribavirin (Virazole)FDA LinkGeneric 01/2006
1	CyanoacrylatesIBA 11/2005
1	Triethylenetetramine (Trien)IBA 07/2005
1	CopperIBA 07/2005
1	Methotrexate (Mexate)FDA LinkGeneric 07/2005
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 05/2005
1	imatinib (Gleevec)FDA Link 05/2005
1	vitamin k5IBA 05/2005
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 07/2004
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 03/2003
1	CyclinsIBA 03/2003
1	Nitric Oxide Synthase (NO Synthase)IBA 05/2002
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 04/2002

Therapy/Procedure

1	Sclerotherapy 11/2005
1	Heterologous Transplantation (Xenotransplantation) 05/2002